Zobrazeno 1 - 10
of 51
pro vyhledávání: '"M. D. Martín Arranz"'
Autor:
C. Froilán Torres, P. Castro Carbajo, R. Pajares Villarroya, R. Plaza Santos, S. Gómez Senent, M. D. Martín Arranz, L. Adán Merino, E. Martín Arranz, N. Manceñido Marcos, R. Peces, D. Benito López
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 101, Iss 4, Pp 288-294 (2009)
El síndrome de lisis tumoral (SLT) es una complicación catastrófica del tratamiento de ciertas enfermedades neoplásicas. Si bien es más frecuente en pacientes con neoplasias hematológicas malignas tras el inicio de la quimioterapia, puede prese
Externí odkaz:
https://doaj.org/article/52dac483c7704941abd06ac8a7ba6808
Autor:
L. Adán Merino, E. Martín Arranz, P. Mora Sanz, C. Froilán Torres, M. D. Martín Arranz, S. Gómez Senent, J. M. Suárez de Parga, J. M. Segura Cabral
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 102, Iss 11, Pp 671-672 (2010)
Externí odkaz:
https://doaj.org/article/d329fdbc5cfa476aab765f8b649a89a1
Autor:
E. Martín Arranz, J. M. Pascual Turrión, M. D. Martín Arranz, E. Burgos, C. Froilán Torres, L. Adán Merino, A. Lorenzo, J. M. Segura Cabral
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 102, Iss 9, Pp 555-556 (2010)
Externí odkaz:
https://doaj.org/article/b040fcc8e0264f5bbc90bbaf249bf7a5
Autor:
M Chaparro, M García Donday, S Riestra, A J Lucendo, J M Benítez, M Navarro-Llavat, J Barrio, V J Morales-Alvarado, M Rivero, D Busquets, E Leo Carnerero, O Merino Ochoa, O Nantes Castillejo, P Navarro, M Van Domselaar, A Gutiérrez Casbas, I Alonso-Abreu, R Mejuto, L Fernández Salazar, M Iborra, M D Martín-Arranz, J R Pineda, M J Sampedro, K Serra Nilsson, A Bouhmidi Assakali, L Batista, C Muñoz Villafranca, I Rodríguez-Lago, D S Ceballos Santos, I Guerra, M Mañosa, I Marín Jimenez, I Vera Mendoza, M Barreiro-de Acosta, E Domènech, M Esteve, V García-Sánchez, P Nos, J Panés, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 17:i50-i54
Background Background: The feasibility of anti-TNF discontinuation in inflammatory bowel disease (IBD) must be proven in clinical trials including patients in clinical, endoscopic, and radiologic remission at the time of anti-TNF withdrawal to make r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8acd9ed996ae8e4fcd0df9c8a1758fb8
https://doi.org/10.1093/ecco-jcc/jjac190.0037
https://doi.org/10.1093/ecco-jcc/jjac190.0037
Autor:
M Aguas Peris, J Del Hoyo, R Vicente, M Barreiro-de Acosta, L Melcarne, A Hernández-Camba, E Alfambra, L Madero, B Sicilia, M Chaparro, M D Martín-Arranz, R Pajares, F Mesonero, M Mañosa, P Martínez, S Chacón, J Tosca, S Marín, L Sanromán, M Calvo, D Monfort, E Saiz, Y Zabana, I Guerra, P Varela, R Faubel, P Corsino, S Porto-Silva, E Brunet, A Gutiérrez, P Nos
Publikováno v:
Journal of Crohn's and Colitis. 17:i35-i37
Background Telemedicine is not consistently superior to standard care in the management of inflammatory bowel disease (IBD). Non-inferiority is an acceptable outcome if telemedicine improves the efficacy and efficiency of care. Owing to the positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be9b6c6b46b41ff151bc3e8c23a874d0
https://doi.org/10.1093/ecco-jcc/jjac190.0026
https://doi.org/10.1093/ecco-jcc/jjac190.0026
Autor:
M Chaparro, A Gutiérrez, C Calviño-Suárez, J M Huguet, M Calvo, M Aguas, R Camargo Camero, M Á de Jorge Turrión, D Hervías Cruz, P López Serrano, S Marín Pedrosa, P Martínez Montiel, M Rivero, R Vicente Lidón, L Arias García, M Arroyo, L Bujanda, M J Casanova, M Figueiras, A J Lucendo, N Manceñido Marcos, L Márquez, M D Martín-Arranz, M Boscá Watts, Y Ber, P Ramírez de la Piscina Urraca, I Pérez-Martínez, V Robles, A Ruiz-Cerulla, J M Vázquez Morón, L Madero, M Barreiro-de Acosta, M Capilla, I Vera Mendoza, D Acosta, Y Brenes, S Hermida, P Parra, M G Donday, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 16:i491-i493
Background The safety of ustekinumab in pregnant patients with inflammatory bowel disease (IBD) and in their offspring has been barely studied. Aims Primary: To know the risk of serious adverse events (SAEs) in women exposed to ustekinumab during pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::937c68b486a568e6c69c84324094d726
https://doi.org/10.1093/ecco-jcc/jjab232.672
https://doi.org/10.1093/ecco-jcc/jjab232.672
Autor:
I Guerra Marina, F Barros, M Chaparro, J M Benítez, M D Martín Arranz, R de Francisco, M Piqueras, L de Castro, A Y Carbajo, F Bermejo, M Mínguez, A Gutiérrez, F Mesonero, F Cañete, C González-Muñoza, M Calvo, B Sicilia, E Alfambra, C A Tardillo, M Rivero, A J Lucendo, L Bujanda, M Van Domselaar, P Almela, L Ramos, M Fernández Sánchez, E Hinojosa, C Verdejo, A Gimenez, I Rodríguez-Lago, N Manceñido, J L Pérez Calle, M D P Moreno, P G Delgado-Guillena, B Antolín, P Ramírez de la Piscina, M J Casanova, Á Carracedo, E Domènech, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 17:i1018-i1019
Background Treatment with thiopurines may be associated with different adverse effects, including acute pancreatitis. Risk factors for developing pancreatitis due to thiopurines in patients with Inflammatory Bowel Disease (IBD) are not clearly identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d90e0b599cba979a0207044c716a2e5
https://doi.org/10.1093/ecco-jcc/jjac190.1035
https://doi.org/10.1093/ecco-jcc/jjac190.1035
Autor:
M I Iborra Colomino, R Ferreiro-Iglesias, M D Martín-Arranz, F Mesonero-Gismero, A Mínguez, S Porto Silva, L García-Ramírez, I García de la Filia, G Bastida, L Nieto García, C Suárez Ferrer, M Aguas, M Barreiro de Acosta, P Nos
Publikováno v:
Journal of Crohn's and Colitis. 17:i629-i630
Background Ustekinumab has been recently approved for the treatment of moderately to severe ulcerative colitis (UC). Data from the UNIFI clinical trial are encouraging; nevertheless, real-world assessment is needed. We assess the effectiveness, safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3ddcb8c8da0d112c6a6f9fc91c90147
https://doi.org/10.1093/ecco-jcc/jjac190.0630
https://doi.org/10.1093/ecco-jcc/jjac190.0630
Autor:
M Calafat Sard, I Pascual, P Nos, J Barrio, A Gutiérrez, M D Martín-Arranz, E Ricart, F Gomollón, M Sierra Ausín, J M Huguet, J Guardiola, I Vera, P Varela, E Iglesias, E Garcia-Planella, L de Castro, M F García Sepulcre, B Sicilia, L Fernández-Salazar, X Calvet, F Muñoz, S García-López, F Bermejo, L Ramos, P Martínez Montiel, R Lorente, J L Cabriada, M Piqueras, I Marín-Jiménez, M Esteve, F Mesonero, E Sesé, J P Gisbert, L Márquez, D Busquets, R Pajares, F Cañete, M Mañosa, E Domènech
Publikováno v:
Journal of Crohn's and Colitis. 17:i766-i767
Background The use of ustekinumab (UST) and vedolizumab (VDZ) as first line therapy for inflammatory bowel disease (IBD) is increasing due to safety reasons and contraindications of anti-TNFs. However, there are no studies evaluating their efficacy a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33fe84d94dea3853b1770f3ecc70d8fc
https://doi.org/10.1093/ecco-jcc/jjac190.0764
https://doi.org/10.1093/ecco-jcc/jjac190.0764
Autor:
I Guerra Marina, F Barros, F Mesonero, R de Francisco, F Cañete, J M Benítez, B Sicilia, M D Martín Arranz, L de Castro, A Y Carbajo, A Gutiérrez, M Calvo, M J Casanova, C González-Muñoza, M Miguel, E Alfambra, M Rivero, A J Lucendo, C A Tardillo, P Almela, L Bujanda, M Van Domselaar, L Ramos, M Fernández Sánchez, E Hinojosa, C Verdejo, A Gimenez, M Piqueras, I Rodríguez-Lago, N Manceñido, J L Pérez Calle, M D P Moreno, P G Delgado, B Antolín, P Ramírez de la Piscina, F Bermejo, Á Carracedo, E Domènech, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 17:i668-i668
Background Treatment with thiopurines in patients with Inflammatory Bowel Disease (IBD) may be associated with different adverse effects, including acute pancreatitis. Our aims were to evaluate the clinical presentation, severity and management of ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90156aacebaa5a0afe31de775ac4782e
https://doi.org/10.1093/ecco-jcc/jjac190.0671
https://doi.org/10.1093/ecco-jcc/jjac190.0671